FDA Reviews Two Promising Oral Antivirals to Help Avoid Severe COVID-19
|
|
Two promising oral antiviral drugs for COVID-19 are under consideration by the FDA. If approved, pharmacists shouldn’t have too hard of a time stocking them. Here’s why: The products, one from Pfizer and the other from Merck and Ridgeback Biotherapeutics, are considered so game-changing the Biden Administration is reportedly planning to spend billions to stockpile the drugs when approved. Read more.
|